|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Trade accounts receivable, net | ||||||||||||||||||||
| Unbilled IDR fees | ||||||||||||||||||||
| Unbilled IDR fees, net | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Prepaid taxes | ||||||||||||||||||||
| Unbilled Independent Dispute Resolution fees, net | ||||||||||||||||||||
| Other current assets, net | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Deficit | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Accrued taxes | ||||||||||||||||||||
| Operating lease obligation, short-term | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued legal contingencies | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| 2025 Revolving Credit Facility | ||||||||||||||||||||
| Operating lease obligation, long-term | ||||||||||||||||||||
| Private Placement Warrants and Unvested Founder Shares | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ deficit: | ||||||||||||||||||||
| Preferred stock, $0.0001 par value — 10,000,000 shares authorized; no shares issued | ||||||||||||||||||||
| Common stock, $0.0001 par value — 1,500,000,000 shares authorized; 17,814,829 and 17,295,582 issued; 16,935,754 and 16,552,723 shares outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock — 29,714 and 19,489 shares | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock - 879,075 and 742,859 shares as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total shareholders’ (deficit)/equity attributable to Claritev Corporation | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| Total liabilities and shareholders’ deficit | ||||||||||||||||||||
Loading...
